Page 9 - David Bartel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Livingston Group Asset Management CO operating as Southport Capital Management acquired a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) in the 4th quarter, Holdings Channel.com reports. The institutional investor acquired 4,175 shares of the biopharmaceutical company’s stock, valued at approximately $708,000. Several other hedge funds have also recently bought and sold shares […]

Stifel Nicolaus reissued their buy rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Rating) in a report released on Thursday morning. Stifel Nicolaus currently has a $215.00 target price on the biopharmaceutical company’s stock. A number of other brokerages have also commented on ALNY. Guggenheim upgraded Alnylam Pharmaceuticals from a neutral rating to a […]

Royal London Asset Management Ltd. cut its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 2.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 40,303 shares of the biopharmaceutical company’s stock after selling 977 shares during the quarter. Royal London […]

Credits: Image courtesy of the Department of Biology. Previous image Next image On Feb. 25, members of the Department of Biology came together with alumni, industry representatives, and supporters to review the department’s challenges and accomplishments during the third annual Friends of Biology gathering. This year’s event was held virtually due to Covid-19 restrictions. Although everyone yearns for in-person events to resume, the new format came with some benefits: This year’s event was the largest Friends of Biology gathering yet, with 195 attendees...